Our findings demonstrate a spermine oxidase/spermine axis that links polyamine metabolism to kidney fibrogenesis and suggest that targeting spermine pathway is a novel potential therapeutic avenue for CKD (Figure 10). This evidence concerns the gene SMOX and chronic kidney disease.